Calnexin was initially identified as an endoplasmic reticulum (ER) type I i
ntegral membrane protein, phosphorylated on its cytosolic domain by ER-asso
ciated protein kinases, Although the role of the ER luminal domain of calne
xin has been established as a constituent of the molecular chaperone machin
ery of the ER, less is known about the role of the cytosolic phosphorylatio
n of calnexin. Analysis by two-dimensional phosphopeptide maps revealed tha
t calnexin was in vitro phosphorylated in isolated microsomes by casein kin
ase 2 (CK2) and extracellular-signal regulated kinase-1 (ERK-1) at sites co
rresponding to those for in vivo phosphorylation, In canine pancreatic micr
osomes, synergistic phosphorylation by CK2 and ERK-1 led to increased assoc
iation of calnexin with membrane-bound ribosomes. In vivo, calnexin-associa
ted ERK-1 activity was identified by co-immunoprecipitation. This activity
was abolished in cells expressing a dominant-negative MEK-1. Activation of
ERK-1 in cells by addition of serum led to a 4-fold increase in ribosome-as
sociated calnexin over unstimulated cells. Taken together with studies reve
aling calnexin association with CK2 and ERK-1, a model is proposed whereby
phosphorylation of calnexin leads to a potential increase in glycoprotein f
olding close to the translocon.